Company: OCEA
Filing Date: 2025-03-20
Form Type: 8-K
Source: 0001493152-25-011046
Chunk: 0

Company: Ocean Biomedical, Inc.
Filing Date: 2025-03-20
Form: 8-K
Item: Item 3.01
Chunk 0
---
Item
3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

Notice
from Nasdaq regarding Nasdaq Listing Requirement for Annual Meeting

On
March 14, 2025, the Company received a notice from Nasdaq that Staff has determined that as of March 13, 2025, the Company’s securities
had a closing bid price of $0.10 or less for ten consecutive trading days. Accordingly, the Company is subject to the provisions contemplated
under Listing Rule 5810(c)(3)(A)(iii) (the “ Low Priced Stocks Rule”). Accordingly, this matter serves as an additional basis
for delisting the Company’s securities from The Nasdaq Stock Market 1

1On December 3, 2024, Staff
notified the Company that the bid price of its listed securities had closed at less than $1 per share over the previous 30 consecutive
business days, and, as a result, did not comply with Listing Rule 5550(a)(2) (the “ Rule”). Therefore, in accordance with
Listing Rule 5810(c)(3)(A), the Company was provided 180 calendar days, or until June 2, 2025, to regain compliance with the Rule.

SIGNATURE

Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.

Date:
March 20, 2025

  OCEAN                                    
  By:                   /s/                
                        Jolie              
                        Chief